Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer

NCT00254891 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

828

Enrollment

INDUSTRY

Sponsor class

Stopped See Termination Reason in Detailed Description

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: PF-3512676 + Paclitaxel + Carboplatin
DRUG: Paclitaxel + Carboplatin

Sponsor

Pfizer